Maintaining Innovation and Safe Technologies Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to issue guidance on payment requirements for certain remote monitoring devices (e.g., glucose monitors) under Medicare medical services. Specifically, the CMS must issue guidance on payment requirements for devices that use artificial intelligence components and that transmit information to health care providers.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 193 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 193
To direct the Secretary of Health and Human Services to issue guidance
on payment under the Medicare program for certain items involving
artificial intelligence.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 3, 2025
Mr. Schweikert introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To direct the Secretary of Health and Human Services to issue guidance
on payment under the Medicare program for certain items involving
artificial intelligence.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Maintaining Innovation and Safe
Technologies Act''.
SEC. 2. GUIDANCE ON MEDICARE PAYMENT FOR CERTAIN ITEMS INVOLVING
ARTIFICIAL INTELLIGENCE.
Not later than January 1, 2027, the Secretary of Health and Human
Services shall use existing communications mechanisms to issue guidance
on requirements for payment under part B of title XVIII of the Social
Security Act (42 U.S.C. 1395j et seq.) for remote monitoring devices,
such as continuous glucose monitors, that--
(1) use an artificial intelligence component (such as a
continuous adjustment component); and
(2) transmit information to a health care provider for
purposes of management and treatment of an individual.
<all>
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line